127 related articles for article (PubMed ID: 31311340)
1. Availability of post-trial access in clinical trials: a review of clinical trial protocols submitted to the research ethics board of the University of the Philippines Manila.
Jimenez EB; Virtudazo JMP; Torres CE; Bernabe RD
Curr Med Res Opin; 2019 Nov; 35(11):1849-1855. PubMed ID: 31311340
[No Abstract] [Full Text] [Related]
2. Post-trial Access in Maternal Vaccine Trials.
Van Roessel IMAA; Mazur NI; Shah SK; Bont L; Van Der Graaf R
Am J Perinatol; 2019 Jul; 36(S 02):S41-S47. PubMed ID: 31238358
[TBL] [Abstract][Full Text] [Related]
3. Post-trial obligations in the Declaration of Helsinki 2013: classification, reconstruction and interpretation.
Mastroleo I
Dev World Bioeth; 2016 Aug; 16(2):80-90. PubMed ID: 26481322
[TBL] [Abstract][Full Text] [Related]
4. Subjects' views of obligations to ensure post-trial access to drugs, care and information: qualitative results from the Experiences of Participants in Clinical Trials (EPIC) study.
Sofaer N; Thiessen C; Goold SD; Ballou J; Getz KA; Koski G; Krueger RA; Weissman JS
J Med Ethics; 2009 Mar; 35(3):183-8. PubMed ID: 19251971
[TBL] [Abstract][Full Text] [Related]
5. Implementing post-trial access plans for HIV prevention research.
Paul A; Merritt MW; Sugarman J
J Med Ethics; 2018 May; 44(5):354-358. PubMed ID: 29487116
[TBL] [Abstract][Full Text] [Related]
6. When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research.
Jacobs E; Murphy-Beiner A; Rouiller I; Nutt D; Spriggs MJ
Neuroethics; 2024; 17(1):3. PubMed ID: 37942467
[TBL] [Abstract][Full Text] [Related]
7. Reporting of informed consent, standard of care and post-trial obligations in global randomized intervention trials: a systematic survey of registered trials.
Cohen ER; O'Neill JM; Joffres M; Upshur RE; Mills E
Dev World Bioeth; 2009 Aug; 9(2):74-80. PubMed ID: 18445072
[TBL] [Abstract][Full Text] [Related]
8. Posttrial Access to Medical Interventions: Intricacies, Challenges, and Solutions.
Singh H; Rao SV; Kakkar AK; Singh J; Manohar HD
Int J Appl Basic Med Res; 2019; 9(1):3-8. PubMed ID: 30820412
[TBL] [Abstract][Full Text] [Related]
9. Post-trial period surveillance for randomised controlled cardiovascular studies: submitted protocols, consent forms and the role of the ethics board.
Zia MI; Heslegrave R; Newton GE
J Med Ethics; 2011 Dec; 37(12):762-5. PubMed ID: 21700724
[TBL] [Abstract][Full Text] [Related]
10. The Council for International Organizations and Medical Sciences (CIOMS) guidelines on ethics of clinical trials.
Macrae DJ
Proc Am Thorac Soc; 2007 May; 4(2):176-8, discussion 178-9. PubMed ID: 17494727
[TBL] [Abstract][Full Text] [Related]
11. The evaluation of complex clinical trial protocols: resources available to research ethics committees and the use of clinical trial registries--a case study.
Homedes N; Ugalde A
J Med Ethics; 2015 Jun; 41(6):464-9. PubMed ID: 25341735
[TBL] [Abstract][Full Text] [Related]
12. Open-label extension studies: do they provide meaningful information on the safety of new drugs?
Day RO; Williams KM
Drug Saf; 2007; 30(2):93-105. PubMed ID: 17253876
[TBL] [Abstract][Full Text] [Related]
13. Conflicts of interest in research involving human beings.
Greco D; Diniz NM
J Int Bioethique; 2008; 19(1-2):143-54, 202-3. PubMed ID: 18664007
[TBL] [Abstract][Full Text] [Related]
14. Post-trial access to investigational drugs in India: addressing challenges in the regulatory framework.
Mehrotra N; Manchikanti P
Med Law Rev; 2024 Feb; 32(1):20-41. PubMed ID: 37616571
[TBL] [Abstract][Full Text] [Related]
15. The project data sphere initiative: accelerating cancer research by sharing data.
Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
[TBL] [Abstract][Full Text] [Related]
16. Inconsistencies in institutional review board decisions: A proposal to regulate the decision-making process.
Ekmekci PE; Guner MD
Bratisl Lek Listy; 2019; 120(2):95-101. PubMed ID: 30793611
[TBL] [Abstract][Full Text] [Related]
17. Investigation of post-trial access views among study participants and stakeholders using photovoice and semistructured interviews.
Ngwenya N; Iwuji C; Petersen N; Myeni N; Nxumalo S; Ngema U; Seeley J
J Med Ethics; 2021 Jun; 48(10):712-7. PubMed ID: 34172519
[TBL] [Abstract][Full Text] [Related]
18. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
19. [Recording and reporting adverse reactions in clinical trials. New legal provisions according to the 12th Law Amending the German Drug Law (AMG) and the Ordinance on GCP (GCP-V)].
Eckhardt K; Cremer-Schaeffer P; König J; Paeschke N
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):173-80. PubMed ID: 15726458
[TBL] [Abstract][Full Text] [Related]
20. Attitudes toward Post-Trial Access to Medical Interventions: A Review of Academic Literature, Legislation, and International Guidelines.
Cook K; Snyder J; Calvert J
Dev World Bioeth; 2016 Aug; 16(2):70-9. PubMed ID: 27378034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
